About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Category Archives: Business/Industry News
BMS Moves to Acquire ImClone
Ok, this is a few days late, but like I said, I was really busy this week. At any rate, here is the complete reprint of the press release from BMS. Bristol-Myers Squibb Proposes to Acquire ImClone Systems for $60.00 … Continue reading
Posted in Business/Industry News
Comments Off on BMS Moves to Acquire ImClone
Genentech Forms Special Committee of Independent Directors to Review Roche Proposal
I’ve decided to add a new category for Business/Industry News. In these cases, the posting will be a re-print of press releases affecting the industry that I find of high interest. This one is from Genentech on the Roche offer. … Continue reading
Posted in Business/Industry News
Comments Off on Genentech Forms Special Committee of Independent Directors to Review Roche Proposal